X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare INDRAPRASTHA MEDICAL with APOLLO HOSPITALS - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs APOLLO HOSPITALS - Comparison Results

APOLLO HOSPITALS 
   Change

What started off in 1979 as a 150 bed hospital in Chennai, Apollo Hospitals Enterprise Limited (AHEL) is now one of the country's premier healthcare providers. The Apollo Hospitals Group includes over 8,500 beds across 50 hospitals (both owned and ma... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL APOLLO HOSPITALS INDRAPRASTHA MEDICAL/
APOLLO HOSPITALS
 
P/E (TTM) x 17.9 75.0 23.9% View Chart
P/BV x 2.7 4.6 57.3% View Chart
Dividend Yield % 3.3 0.5 675.6%  

Financials

 INDRAPRASTHA MEDICAL   APOLLO HOSPITALS
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-14
APOLLO HOSPITALS
Mar-17
INDRAPRASTHA MEDICAL/
APOLLO HOSPITALS
5-Yr Chart
Click to enlarge
High Rs411,443 2.8%   
Low Rs291,111 2.6%   
Sales per share (Unadj.) Rs72.0521.4 13.8%  
Earnings per share (Unadj.) Rs3.99.4 41.0%  
Cash flow per share (Unadj.) Rs6.932.0 21.7%  
Dividends per share (Unadj.) Rs1.806.00 30.0%  
Dividend yield (eoy) %5.10.5 1,089.7%  
Book value per share (Unadj.) Rs20.4263.6 7.7%  
Shares outstanding (eoy) m91.67139.13 65.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.52.4 19.9%   
Avg P/E ratio x9.1135.5 6.7%  
P/CF ratio (eoy) x5.139.9 12.7%  
Price / Book Value ratio x1.74.8 35.6%  
Dividend payout %46.663.7 73.1%   
Avg Mkt Cap Rs m3,222177,641 1.8%   
No. of employees `0003.149.7 6.2%   
Total wages/salary Rs m1,41811,965 11.9%   
Avg. sales/employee Rs Th2,125.71,458.4 145.8%   
Avg. wages/employee Rs Th456.6240.5 189.9%   
Avg. net profit/employee Rs Th114.126.4 432.9%   
INCOME DATA
Net Sales Rs m6,60072,549 9.1%  
Other income Rs m186225 82.5%   
Total revenues Rs m6,78672,774 9.3%   
Gross profit Rs m7337,286 10.1%  
Depreciation Rs m2813,140 9.0%   
Interest Rs m962,574 3.7%   
Profit before tax Rs m5421,797 30.1%   
Minority Interest Rs m0424 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m187910 20.6%   
Profit after tax Rs m3541,311 27.0%  
Gross profit margin %11.110.0 110.6%  
Effective tax rate %34.650.6 68.3%   
Net profit margin %5.41.8 297.0%  
BALANCE SHEET DATA
Current assets Rs m1,47321,863 6.7%   
Current liabilities Rs m1,9209,799 19.6%   
Net working cap to sales %-6.816.6 -40.7%  
Current ratio x0.82.2 34.4%  
Inventory Days Days723 29.1%  
Debtors Days Days3638 94.5%  
Net fixed assets Rs m2,94749,968 5.9%   
Share capital Rs m917696 131.8%   
"Free" reserves Rs m95535,983 2.7%   
Net worth Rs m1,87136,679 5.1%   
Long term debt Rs m25829,955 0.9%   
Total assets Rs m4,48881,165 5.5%  
Interest coverage x6.71.7 392.8%   
Debt to equity ratio x0.10.8 16.9%  
Sales to assets ratio x1.50.9 164.5%   
Return on assets %10.04.8 209.4%  
Return on equity %18.93.6 529.7%  
Return on capital %29.97.2 415.8%  
Exports to sales %00-   
Imports to sales %1.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m116NA-   
Fx inflow Rs m1,116922 121.0%   
Fx outflow Rs m218963 22.6%   
Net fx Rs m898-41 -2,188.9%   
CASH FLOW
From Operations Rs m5815,756 10.1%  
From Investments Rs m-218-9,747 2.2%  
From Financial Activity Rs m-3615,468 -6.6%  
Net Cashflow Rs m21,476 0.1%  

Share Holding

Indian Promoters % 49.4 34.4 143.6%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 1.3 4.0 32.5%  
FIIs % 0.5 41.6 1.2%  
ADR/GDR % 0.0 0.8 -  
Free float % 47.2 19.3 244.6%  
Shareholders   38,169 33,376 114.4%  
Pledged promoter(s) holding % 0.0 64.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   FORTIS HEALTHCARE  



Today's Market

Indian Indices Trade Strong; Metal, Pharma Stocks Lead Gains(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading above the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Feb 23, 2018 02:21 PM

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL 8-QTR ANALYSIS

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS